Kimia Farma Persero Tbk (KAEF)

PT Kimia Farma Tbk engages in the manufacturing and sale of pharmaceutical products in Indonesia, Saudi Arabia, the United States, the Netherlands, the United Kingdom, China, Malaysia, and internationally. The company operates through the Manufacturing, Distribution, Retail, and Other segments. It provides generic, ethical, licensed, and narcotic medicines; over-the-counter medicines and herbs; tablets, injections, syrups, raw materials, medical devices, and cosmetic products. The company is also involved in research and development activities, promotion, and the manufacturing and marketing of quinine and essential oils, active pharmaceutical ingredients, and high-function chemicals; health food and effervescent tablets; quinine salt and related derivatives; and castor oil and edible oil. In addition, it provides clinical laboratory services that include routine, referral, and research-supporting laboratory examinations, as well as non-laboratory examinations such as complete physicals, spirometry, audiometry, X-rays, panoramic X-rays, electrocardiograms, ultrasonography, treadmill tests, etc.; and occupational health and nutritional consultations, as well as retails and distributes pharmaceutical products. Further, the company offers laboratory tests, including drug monitoring, narcotics, allergy tests, tumor markers, cardio markers, fertility tests, immunology, serology, urinalysis, hematology, kidney function tests, liver function tests, diabetes mellitus, biomolecular viruses, oncology, and others. The company exports its products to Asia, Europe, Australia, Africa, and the United States. It distributes its products through pharmaceutical wholesalers. PT Kimia Farma Tbk was founded in 1817 and is headquartered in Jakarta, Indonesia.